Determinants and prognostic information provided by pulse pressure in patients with coronary artery disease

M J Domanski1, K Sutton-Tyrrell, G F Mitchell

  • 1Clinical Trials Group, Divison of Epidemiology and Clinical Applications, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA. Domanskm@NIH.GOV

Insights

Increased pulse pressure (PP), a marker of arterial stiffness, independently predicts mortality in patients after revascularization. Key predictors of higher PP include hypertension, older age, diabetes, and noncoronary vascular disease.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Clinical Cardiology

Background:

  • Arterial stiffness, indicated by increased pulse pressure (PP), is linked to adverse cardiovascular outcomes.
  • The prognostic value of PP in patients post-revascularization remains unclear.

Purpose of the Study:

  • To investigate the prognostic importance of PP after coronary revascularization.
  • To identify predictors of elevated PP in this patient population.

Main Methods:

  • Analysis of data from the Balloon Angioplasty Revascularization Investigation (BARI) cohort.
  • Utilized regression analyses to determine associations between baseline characteristics, PP, and 5-year mortality.
  • Cox regression models were employed to assess independent predictors of mortality.

Main Results:

  • Baseline factors independently associated with higher PP included higher mean arterial pressure, older age, female sex, noncoronary vascular disease, diabetes mellitus, and hypertension.
  • PP was an independent predictor of 5-year all-cause mortality (p = 0.008) after coronary revascularization.
  • The association between PP and mortality remained significant after adjusting for mean arterial pressure, but diminished with the inclusion of renal and noncoronary vascular disease.

Conclusions:

  • Elevated pulse pressure is an independent predictor of mortality following coronary revascularization.
  • Factors such as hypertension, older age, diabetes, and noncoronary vascular disease contribute to increased arterial stiffness (PP) in these patients.

Related Concept Videos

Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...